IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-60714-4.html
   My bibliography  Save this article

Increase in H5N1 vaccine antibodies confers cross-neutralization of highly pathogenic avian influenza H5N1

Author

Listed:
  • Xiande Huang

    (National Institutes for Food and Drug Control (NIFDC))

  • Dan Yu

    (Sinovac Biotech)

  • Ling Pan

    (Shenyang Pharmaceutical University)

  • Xi Wu

    (National Institutes for Food and Drug Control (NIFDC))

  • Jun Li

    (Sinovac Biotech)

  • Dayan Wang

    (Chinese Center for Disease Control and Prevention (China CDC))

  • Liqi Liu

    (Chinese Center for Disease Control and Prevention (China CDC))

  • Chenyan Zhao

    (National Institutes for Food and Drug Control (NIFDC))

  • Weijin Huang

    (National Institutes for Food and Drug Control (NIFDC))

Abstract

H5N1, a highly pathogenic avian influenza virus, presents pandemic risks due to its ability to adapt and spread among mammalian species. Vaccination may control its spread, but the effectiveness of existing H5N1 vaccines against circulating strains, especially clade 2.3.4.4b, remains uncertain. In this study, we assess neutralizing antibody responses to global circulating H5N1 strains, using sera from individuals vaccinated with an inactivated H5N1 vaccine (NCT00535665). Neutralization is measured against 17 pseudoviruses, representing circulating and vaccine H5 strains. Our results indicate that broad protective effects are observed only when high antibody titers are achieved by vaccination. Correlation analysis estimates that a pseudovirus-based neutralization titer of at least 1:980 is required to achieve a cross-protection rate above 60%. The findings suggest that the current H5N1 vaccine can elicit cross-neutralization of circulating H5N1 strains, if high antibody titers are achieved. Until updated H5N1 vaccines are developed, this vaccine may serve as a bridging measure.

Suggested Citation

  • Xiande Huang & Dan Yu & Ling Pan & Xi Wu & Jun Li & Dayan Wang & Liqi Liu & Chenyan Zhao & Weijin Huang, 2025. "Increase in H5N1 vaccine antibodies confers cross-neutralization of highly pathogenic avian influenza H5N1," Nature Communications, Nature, vol. 16(1), pages 1-7, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60714-4
    DOI: 10.1038/s41467-025-60714-4
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-60714-4
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-025-60714-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-60714-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.